Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Management team appointments at Biological E

This article was originally published in Scrip

Executive Summary

Biological E (India), a manufacturer of vaccines, biologics and pharmaceutical products, has made three appointments to its management team: Dr Martin Reers is named senior vice-president of technical operations, having most recently served as vice-president of technology development global, manufacturing sciences at Novartis/Chiron Vaccines; Dr Gopalam Somasekhar joins as senior vice-president of development – he was previously associate director at Wyeth Vaccines; and Dr Krish Venkat is appointed senior vice-president of quality, having previously worked as consultant to US biotech and pharmaceutical companies on quality and regulatory issues, and vaccine development, as a principal at Anven Research.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

SC000321

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel